Loading clinical trials...
Loading clinical trials...
Efficacy of a Non-invasive Vestibular System Masking for the Abortive Treatment of Vertigo for Patients With Acute Unilateral Vestibulopathy (AUV)
Conditions
Interventions
Otoband
Placebo Device
Locations
1
United States
University of Miami Health System
Miami, Florida, United States
Start Date
June 1, 2022
Primary Completion Date
May 30, 2024
Completion Date
June 30, 2024
Last Updated
March 22, 2022
NCT07169851
NCT07403370
NCT06326983
NCT07274215
NCT07271147
NCT04150614
Lead Sponsor
Otolith Labs
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions